participants receive structured training from the trial healthcare team before self-administering
Long-Term GLP-1 Use vs
Microbial Shifts Observed: Liraglutide reliably boosts beneficial microbes like Akkermansia muciniphila , Faecalibacterium prausnitzii , Lactobacillus reuteri , Bifidobacterium , and SCFA-producerssupporting gut barrier integrity, reducing inflammation, and promoting metabolic health Semaglutide shows promiseraising Akkermansia and other good playersbut in some cases also narrows microbial diversity, depending on diet, health status, and treatment duration
Behaviors were classified as feeding, drinking, pica (consumption of nonnutritive material), activity (locomotor, rearing, grooming), or stationary